Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults.

Frontiers in endocrinology - 1 Jan 2026

Zheng Baojia, Li Chan, Fang Zhaoxiong, Xu Wenning, Xiao Feina, Su Lili, Chen Xiaoling, Xiang Yali

Abstract excerpt

Objective: Prediabetes exhibits a high comorbidity rate with non-alcoholic fatty liver disease (NAFLD), significantly increasing the risks of diabetes progression and other complications. This study aims to clarify the differences in NAFLD risk among different prediabetes phenotypes and explore their underlying associations. Methods: A cohort of 2127 prediabetic individuals aged 18-59 years was enrolled. Latent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Insulin Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Prediabetic State

Share to Prevalence

Share to Risk Factors

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 42318224
DOI: 10.3389/fendo.2026.1819674
PMCID: PMC13271963

Genes

LPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults.PMID 42318224Read ↗

Phenotypes of prediabetes and stratification of cardiometabolic risk.Semantic proximity Read ↗

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.Semantic proximity Read ↗

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.Semantic proximity Read ↗

Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusSemantic proximity Read ↗

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical ImplicationsSemantic proximity Read ↗

Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.Semantic proximity Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.Semantic proximity Read ↗

Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease.Semantic proximity Read ↗

Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision makingSemantic proximity Read ↗

Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtypingSemantic proximity Read ↗

From NHANES to Network Pharmacology: HOMA-IR Mechanisms in Concurrent MASLD and Type 2 DiabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.